Clinical trial · Interventional
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer (Adenocarcinoma) | Malignant Prostate Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dyadic Co-learning Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control Group
- description
- Participants in the control group will receive routine care.
- type
- EXPERIMENTAL
- label
- Dyadic Co-learning Intervention Group
- description
- Participants in the experimental group will receive routine care plus an 8-week Dyadic Co-learning Intervention.
- interventionNames
- Other: Dyadic Co-learning Intervention
Primary outcomes (1)
- measure
- Family Resilience (patients and spouses)
- timeFrame
- Before the intervention (pre-test), and at the 10th and 16th weeks after the pre-test
- description
- This study will adopt the Chinese version of the Walsh Family Resilience Questionnaire to assess family resilience in patients with prostate cancer and their spouses. The scale uses a 5-point Likert rating, ranging from 1 (Never) to 5 (Always). Total scores range from 26 to 130, with higher scores indicating greater levels of family resilience.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: For Patients: 1. Diagnosed with prostate cancer by a board-certified urologist. 2. Has either decided on a treatment plan or completed treatment within the past two years. 3. Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. For Spouses: 1. Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older. 2. Must have a Barthel Index score of 91 or above, indicating good functional independence. Exclusion Criteria: Either the patient or the spouse will be excluded if: 1. Diagnosed with another type of cancer. 2. Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
References
Publications (5)
- BACKGROUNDLin CC, Chang AP, Chen ML, Cleeland CS, Mendoza TR, Wang XS. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul;32(1):52-9. doi: 10.1016/j.jpainsymman.2005.12.019. PMID 16824985
- BACKGROUNDSzymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010 Nov;76(5):1245-50. doi: 10.1016/j.urology.2010.01.027. Epub 2010 Mar 28. PMID 20350762
- BACKGROUNDWang A, Lu J. Validation of the Chinese version of the Walsh Family Resilience Questionnaire. Fam Process. 2023 Mar;62(1):368-386. doi: 10.1111/famp.12751. Epub 2022 Feb 23. PMID 35195282
- BACKGROUNDMeng M, He J, Guan Y, Zhao H, Yi J, Yao S, Li L. Factorial Invariance of the 10-Item Connor-Davidson Resilience Scale Across Gender Among Chinese Elders. Front Psychol. 2019 May 31;10:1237. doi: 10.3389/fpsyg.2019.01237. eCollection 2019. PMID 31214071
- DERIVEDChien CH, Chuang CK, Wu CT, Pang ST, Yu KJ, Lin PH, Liu KL. Theory-based dyadic co-learning intervention to enhance family resilience in men with prostate cancer and their spouses in Taiwan: protocol for a randomised controlled trial. BMJ Open. 2026 Jun 28;16(6):e118902. doi: 10.1136/bmjopen-2026-118902. PMID 42366001